Utah Medical Products, Inc. (UTMD)
Stock Price Chart
Key Info
| Market Cap | 309.38M |
| Revenue (ttm) | 44.01M |
| Net Income (ttm) | 12.52M |
| Shares Out | 3.64M |
| EPS (ttm) | 3.37 |
| PE Ratio | 25.20 |
| Forward PE | n/a |
| Dividend | $1.12 |
| Dividend Yield | 1.32% |
Stock Quote
| Trading Day | Oct 23, 2020 |
| Last Price | $84.92 |
| Previous Close | $84.00 |
| Change ($) | 0.92 |
| Change (%) | 1.10% |
| Day's Open | 84.55 |
| Day's Range | 84.18 - 85.50 |
| Day's Volume | 6,847 |
| 52-Week Range | 75.33 - 112.26 |
More Stats
| Market Cap | 309.38M |
| Enterprise Value | 267.38M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | Sep 14, 2020 |
| Shares Outstanding | 3.64M |
| Float | 3.39M |
| EPS (basic) | 3.38 |
| EPS (diluted) | 3.37 |
| FCF / Share | 5.56 |
| Dividend | $1.12 |
| Dividend Yield | 1.32% |
| Earnings Yield | 3.97% |
| FCF Yield | 6.54% |
| Payout Ratio | 33.00% |
| Shares Short | 76,088 |
| Short Ratio | 6.58 |
| Short % of Float | 2.24% |
| Beta | 0.35 |
| PE Ratio | 25.20 |
| Forward PE | n/a |
| P/FCF Ratio | 15.28 |
| PS Ratio | 7.03 |
| PB Ratio | 3.21 |
| Revenue | 44.01M |
| Operating Income | 14.89M |
| Net Income | 12.52M |
| Free Cash Flow | 20.24M |
| Net Cash | 42.00M |
| Net Cash / Share | 11.53 |
| Gross Margin | 66.95% |
| Operating Margin | 33.83% |
| Profit Margin | 28.40% |
| FCF Margin | 45.99% |
| ROA | 9.01% |
| ROE | 13.23% |
| ROIC | 79.40% |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46.90 | 42.00 | 41.41 | 39.30 | 40.16 | 41.28 | 40.49 | 41.55 | 37.86 | 25.12 |
| Revenue Growth | 11.68% | 1.41% | 5.38% | -2.14% | -2.72% | 1.94% | -2.55% | 9.75% | 50.71% | - |
| Gross Profit | 29.47 | 26.31 | 26.40 | 23.69 | 24.19 | 24.98 | 24.27 | 25.31 | 22.40 | 13.21 |
| Operating Income | 17.63 | 18.70 | 19.01 | 16.19 | 15.65 | 16.20 | 14.83 | 15.20 | 11.84 | 8.92 |
| Net Income | 14.73 | 18.56 | 8.51 | 12.13 | 11.84 | 11.38 | 11.41 | 10.17 | 7.41 | 6.01 |
| Shares Outstanding | 3.72 | 3.73 | 3.72 | 3.76 | 3.75 | 3.74 | 3.74 | 3.68 | 3.64 | 3.62 |
| Earnings Per Share | 3.94 | 4.95 | 2.28 | 3.22 | 3.14 | 3.02 | 3.02 | 2.74 | 2.03 | 1.65 |
| EPS Growth | -20.4% | 117.11% | -29.19% | 2.55% | 3.97% | 0% | 10.22% | 34.98% | 23.03% | - |
| Dividend Per Share | 1.11 | 1.09 | 1.07 | 1.05 | 1.03 | 1.01 | 0.99 | 0.97 | 0.95 | 1.67 |
| Dividend Growth | 1.84% | 1.88% | 1.91% | 1.95% | 1.99% | 2.03% | 2.07% | 2.12% | -43.24% | - |
| Operating Cash Flow | 17.06 | 16.83 | 16.91 | 14.53 | 13.80 | 15.39 | 12.31 | 13.56 | 11.37 | 7.16 |
| Capital Expenditures | -0.54 | 0.46 | -1.60 | -3.29 | -0.18 | -1.11 | -0.34 | -0.25 | -0.25 | -1.53 |
| Free Cash Flow | 16.52 | 17.29 | 15.31 | 11.24 | 13.63 | 14.28 | 11.97 | 13.31 | 11.12 | 5.63 |
| Cash & Equivalents | 42.79 | 51.11 | 39.96 | 26.36 | 23.33 | 19.33 | 14.45 | 8.91 | 6.60 | 18.54 |
| Total Debt | 0.38 | - | - | - | - | 4.87 | 9.12 | 13.00 | 21.67 | 1.12 |
| Net Cash / Debt | 42.41 | 51.11 | 39.96 | 26.36 | 23.33 | 14.47 | 5.33 | -4.09 | -15.07 | 17.41 |
| Assets | 110 | 99.77 | 92.75 | 76.19 | 79.18 | 81.08 | 80.71 | 76.94 | 76.39 | 41.24 |
| Liabilities | 8.69 | 10.78 | 14.62 | 6.95 | 9.53 | 16.52 | 20.13 | 25.96 | 35.63 | 3.45 |
| Book Value | 101 | 88.99 | 78.12 | 69.24 | 69.65 | 64.56 | 60.58 | 50.97 | 40.76 | 37.79 |
Company Profile
Company Details
| Full Name | Utah Medical Products, Inc. |
| Country | United States |
| Employees | 182 |
| CEO | Kevin Leighton Cornwell |
Stock Information
| Ticker Symbol | UTMD |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Unique Identifier | NASDAQ: UTMD |
Description
Utah Medical Products manufactures and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; NUTRI-CATH, a feeding device; MYELO-NATE, a lumbar sampling kit; HEMO-NATE, a disposable filter; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides Filshie Clip system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants and manufacturer representatives. The company was founded in 1978 and is headquartered in Midvale, Utah.